An investigational oral microbiome-based therapeutic safely and effectively prevented recurrent Clostridium difficile infection in patients with multiple recurrent infections, according to results from a phase 1b/2 trial.
|Emory Health Now (blog)|| - |
Bacterial spores in capsules taken by mouth can prevent recurrent C. difficile infection, results from a preliminary study suggest.
Exposure to fluoroquinolone and macrolide were found to be associated with infection by the epidemic BI/NAP1/027 strain of Clostridium difficile, which is highly resistant to these antibiotics, according to recent study data.
|See realtime coverage|
|EurekAlert (press release)|| - |
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health ...
Administration of a Saccharomyces boulardii probiotic treatment to hospital patients receiving antibiotics appeared to have no impact on the incidence of antibiotic- and Clostridium difficile-associated diarrhea, according to the results of a recent trial.
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant Clostridium difficile, one of the fastest-growing “superbugs,” according to a new study led by Stuart Johnson, MD, of Loyola University. C ...
The Drugs for Clostridium Difficile Infections market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Clostridium difficile is a spore-forming bacterium that causes gastrointestinal infections commonly associated with antibiotic use and health care contact.
ResearchMoz_Edit_250x25014 ResearchMoz.us include new market research report”Global Drugs for Clostridium Difficile Infections Industry 2015 Market Research Report” to its huge collection of research reports.
The Drugs for Clostridium Difficile Infections market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
|Gastroenterology & Endoscopy News|| - |
Ultraviolet robots reduced the transmission rate of Clostridium difficile by 25% among hospitalized cancer patients, mostly among those with hematologic malignancies, a group more vulnerable to hospital-acquired infections (HAIs).
However, one bug is on the rise in California: the worm-shaped Clostridium difficile, which infects the intestine, causes diarrhea and fever, and can be life-threatening.
Clostridium difficile, a Gram-positive, spore-forming, toxin-producing, non-invasive, anaerobic bacterium, is the causative organism of C. difficile infection (CDI), which is commonly associated with colitis, as well as C. difficile-associated diarrhea ...
Brome-Missisquoi-Perkins hospital spokesperson Julie Constantineau confirmed the geriatric ward of the institution has been dealing with a C. difficile outbreak since Dec.30. Visitors are still allowed into the wing during regular hours, but are asked ...
Diarree door Clostridium difficile is een frequente nosocomiale infectieziekte die meestal het gevolg is van inname van antibiotica zoals clindamycine, cefalosporines, penicillines en chinolonen. Andere risicofactoren zijn gevorderde leeftijd ...